Literature DB >> 18508820

Early mortality in patients with community-acquired pneumonia: causes and risk factors.

C Garcia-Vidal1, N Fernández-Sabé, J Carratalà, V Díaz, R Verdaguer, J Dorca, F Manresa, F Gudiol.   

Abstract

The first 48 h of evolution of patients with community-acquired pneumonia (CAP) are critical. The aim of the present study was to determine the frequency, causes and factors associated with early mortality in CAP. Nonimmunocompromised adults hospitalised with CAP were prospectively observed from 1995 to 2005. Early deaths, defined as death due to any cause < or = 48 h after admission, were compared with all patients who survived > 48 h. Furthermore, early deaths were compared with late deaths (patients who died > 48 h) and with survivors. Of 2,457 patients, 57 (2.3%) died < or = 48 h after admission. Overall mortality was 7.7%. The main causes of early mortality were respiratory failure and septic shock/multiorgan failure. Independent factors associated with early deaths were increased age, altered mental status at presentation, multilobar pneumonia, shock at admission, pneumococcal bacteraemia and discordant empiric antibiotic therapy. Currently, early mortality is relatively low and is caused by pneumonia-related factors. It occurs mainly among the elderly and in patients presenting with altered mental status, multilobar pneumonia and septic shock. Pneumococcal bacteraemia and discordant antibiotic therapy, mainly due to lack of coverage against Pseudomonas aeruginosa are also significant risk factors.

Entities:  

Mesh:

Year:  2008        PMID: 18508820     DOI: 10.1183/09031936.00128107

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  23 in total

1.  Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.

Authors:  J M Bordon; R Fernandez-Botran; T L Wiemken; P Peyrani; S M Uriarte; F W Arnold; L Rodriquez-Hernandez; M J Rane; R R Kelley; L E Binford; S Uppatla; R Cavallazzi; F Blasi; S Aliberti; M I Restrepo; S Fazeli; A Mathur; M Rahmani; K Ayesu; J Ramirez
Journal:  Infection       Date:  2015-09-30       Impact factor: 3.553

Review 2.  Pneumonia in frail older patients: an up to date.

Authors:  Marco Falcone; Francesco Blasi; Francesco Menichetti; Federico Pea; Francesco Violi
Journal:  Intern Emerg Med       Date:  2012-06-12       Impact factor: 3.397

3.  Early cardiac arrest in patients hospitalized with pneumonia: a report from the American Heart Association's Get With The Guidelines-Resuscitation Program.

Authors:  Gordon E Carr; Trevor C Yuen; John F McConville; John P Kress; Terry L VandenHoek; Jesse B Hall; Dana P Edelson
Journal:  Chest       Date:  2011-12-22       Impact factor: 9.410

4.  Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia.

Authors:  S Padrones; C Garcia-Vidal; S Fernández-Serrano; A Fernández; C Masuet; J Carratalà; M Coromines; C Ardanuy; F Gudiol; F Manresa; J Dorca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-22       Impact factor: 3.267

5.  Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008.

Authors:  Yi-Tsung Lin; Yuan-Yu Jeng; Te-Li Chen; Chang-Phone Fung
Journal:  BMC Infect Dis       Date:  2010-10-25       Impact factor: 3.090

6.  Clinically relevant model of pneumococcal pneumonia, ARDS, and nonpulmonary organ dysfunction in mice.

Authors:  Jeffrey E Gotts; Olivier Bernard; Lauren Chun; Roxanne H Croze; James T Ross; Nicolas Nesseler; Xueling Wu; Jason Abbott; Xiaohui Fang; Carolyn S Calfee; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-09-11       Impact factor: 5.464

7.  Predicting Mycoplasma pneumoniae and Chlamydophila pneumoniae in community-acquired pneumonia (CAP) pneumonia: epidemiological study of respiratory tract infection using multiplex PCR assays.

Authors:  Naoto Ishimaru; Satoshi Suzuki; Toshio Shimokawa; Yusaku Akashi; Yuto Takeuchi; Atsuo Ueda; Saori Kinami; Hisashi Ohnishi; Hiromichi Suzuki; Yasuharu Tokuda; Tetsuhiro Maeno
Journal:  Intern Emerg Med       Date:  2021-05-13       Impact factor: 3.397

8.  Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study.

Authors:  Nicolas Mongardon; Adeline Max; Adrien Bouglé; Frédéric Pène; Virginie Lemiale; Julien Charpentier; Alain Cariou; Jean-Daniel Chiche; Jean-Pierre Bedos; Jean-Paul Mira
Journal:  Crit Care       Date:  2012-08-15       Impact factor: 9.097

9.  Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial.

Authors:  Silvia Fernández-Serrano; Jordi Dorca; Carolina Garcia-Vidal; Núria Fernández-Sabé; Jordi Carratalà; Ana Fernández-Agüera; Mercè Corominas; Susana Padrones; Francesc Gudiol; Frederic Manresa
Journal:  Crit Care       Date:  2011-03-15       Impact factor: 9.097

Review 10.  Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  Christophe Marti; Nicolas Garin; Olivier Grosgurin; Antoine Poncet; Christophe Combescure; Sebastian Carballo; Arnaud Perrier
Journal:  Crit Care       Date:  2012-07-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.